Mundipharma expands its European footprint with Herceptin biosimilar
Mundipharma partners with Prestige to commercialize and supply a biosimilar to Roche’s Herceptin, for patients with breast, gastric and gastroesophageal cancer.
Archives for July 4, 2019
Regeneron and Sanofi’s PD-1 inhibitor given go-ahead by EC
Regeneron and Sanofi’s Libtayo is granted marketing authorization by the European Commission for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma.
Sartorius creates vessel for its bioreactor system to improve scalability
Sartorius launches a new vessel for its ambr 250 modular bioreactor system to potentially accelerate cell and gene therapy process development and scale up into cGMP single-use bioreactors and bags.